| Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers M Panagopoulou, M Karaglani, I Balgkouranidou, E Biziota, T Koukaki, ... Oncogene 38 (18), 3387-3401, 2019 | 142 | 2019 |
| Lung cancer epigenetics: emerging biomarkers I Balgkouranidou, T Liloglou, ES Lianidou Biomarkers in medicine 7 (1), 49-58, 2013 | 130 | 2013 |
| Mesenchymal cells from human amniotic fluid survive and migrate after transplantation into adult rat brain S Cipriani, D Bonini, E Marchina, I Balgkouranidou, L Caimi, GG Zucconi, ... Cell Biology International 31 (8), 845-850, 2007 | 117 | 2007 |
| ‘One night’sleep deprivation stimulates hippocampal neurogenesis GG Zucconi, S Cipriani, I Balgkouranidou, R Scattoni Brain research bulletin 69 (4), 375-381, 2006 | 117 | 2006 |
| Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival I Balgkouranidou, A Karayiannakis, D Matthaios, H Bolanaki, G Tripsianis, ... Clinical chemistry and laboratory medicine 51 (7), 1505-1510, 2013 | 106 | 2013 |
| SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer I Balgkouranidou, M Chimonidou, G Milaki, E Tsaroucha, S Kakolyris, ... Clinical Chemistry and Laboratory Medicine (CCLM) 54 (8), 1385-1393, 2016 | 91 | 2016 |
| Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients I Balgkouranidou, D Matthaios, A Karayiannakis, H Bolanaki, P Michailidis, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 778, 46-51, 2015 | 89 | 2015 |
| Molecular pathogenesis of pancreatic cancer and clinical perspectives D Matthaios, P Zarogoulidis, I Balgouranidou, E Chatzaki, S Kakolyris Oncology 81 (3-4), 259-272, 2011 | 86 | 2011 |
| Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer I Balgkouranidou, M Chimonidou, G Milaki, EG Tsarouxa, S Kakolyris, ... British journal of cancer 110 (8), 2054-2062, 2014 | 84 | 2014 |
| Copper deficiency elicits glial and neuronal response typical of neurodegenerative disorders GG Zucconi, S Cipriani, R Scattoni, I Balgkouranidou, DP Hawkins, ... Neuropathology and applied neurobiology 33 (2), 212-225, 2007 | 67 | 2007 |
| Methylation status of the APC and RASSF1A promoter in cell‑free circulating DNA and its prognostic role in patients with colorectal cancer D Matthaios, I Balgkouranidou, A Karayiannakis, H Bolanaki, N Xenidis, ... Oncology letters 12 (1), 748-756, 2016 | 62 | 2016 |
| Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer M Kioulafa, I Balkouranidou, G Sotiropoulou, L Kaklamanis, D Mavroudis, ... International journal of cancer 125 (12), 2887-2892, 2009 | 44 | 2009 |
| Circulating cell‐free DNA release in vitro: kinetics, size profiling, and cancer‐related gene methylation M Panagopoulou, M Karaglani, I Balgkouranidou, C Pantazi, G Kolios, ... Journal of cellular physiology 234 (8), 14079-14089, 2019 | 37 | 2019 |
| PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis C Nikolaidis, E Nena, M Panagopoulou, I Balgkouranidou, M Karaglani, ... Cancer epidemiology 39 (5), 682-686, 2015 | 37 | 2015 |
| KMT2C promoter methylation in plasma‐circulating tumor DNA is a prognostic biomarker in non‐small cell lung cancer S Mastoraki, I Balgkouranidou, E Tsaroucha, A Klinakis, V Georgoulias, ... Molecular oncology, 2020 | 24 | 2020 |
| Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients EI Karamitrousis, I Balgkouranidou, N Xenidis, K Amarantidis, E Biziota, ... Technology in cancer research & treatment 20, 1533033820973279, 2021 | 19 | 2021 |
| ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker M Panagopoulou, A Drosouni, D Fanidis, M Karaglani, I Balgkouranidou, ... International journal of molecular sciences 23 (7), 3717, 2022 | 17 | 2022 |
| Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer V Tserpeli, D Stergiopoulou, D Londra, L Giannopoulou, P Buderath, ... Cancers 14 (1), 4, 2021 | 15 | 2021 |
| Search for pharmacoepigenetic correlations in type 2 diabetes under sulfonylurea treatment M Karaglani, G Ragia, M Panagopoulou, I Balgkouranidou, E Nena, ... Experimental and Clinical Endocrinology & Diabetes 127 (04), 226-233, 2019 | 12 | 2019 |
| Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer M Panagopoulou, M Lambropoulou, I Balgkouranidou, E Nena, ... Tumor Biology 39 (4), 1010428317697557, 2017 | 12 | 2017 |
